Publications by authors named "Stacey Hembruff"

Claim this Profile
O
Oncology Workforce: More than Meets the Eye.
Sierra Wood, Joseph Hines, Pauline Horton, Jessica Leib, Stacey Hembruff

J Cancer Educ· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
influences whole body metabolism in humanized mice.
Stacey Hembruff, Alexander Dekonenko, John P Thyfault, Mihaela E Sardiu, Michael P Washburn

Am J Physiol Endocrinol Metab· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual targeting of Aurora Kinase A and poly (ADP-ribose) polymerase as a therapeutic option for patients with ovarian cancer: preclinical evaluations.
Soumya M Turaga, Stacey L Hembruff, Masha G Savelieff, Arnab Ghosh, Rajni V Puri

J Cancer Res Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editor's Note: Superior Efficacy of a Combined Epigenetic Therapy against Human Mantle Cell Lymphoma Cells.
Warren Fiskus, Rekha Rao, Ramesh Balusu, Siddhartha Ganguly, Jianguo Tao, Stacey L Hembruff

Clin Cancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inducing Mitotic Catastrophe as a Therapeutic Approach to Improve Outcomes in Ewing Sarcoma.
Soumya M Turaga, Vikalp Vishwakarma, Stacey L Hembruff, Benjamin K Gibbs, Priya Sabu

Cancers (Basel)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superior efficacy of a combined epigenetic therapy against human mantle cell lymphoma cells.
Warren Fiskus, Rekha Rao, Ramesh Balusu, Siddhartha Ganguly, Jianguo Tao, Stacey L Hembruff

Clin Cancer Res· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cells.
Warren Fiskus, Stacey L Hembruff, Rekha Rao, Priyanka Sharma, Ramesh Balusu

Breast Cancer Res Treat· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells.
Rekha Rao, Ramesh Balusu, Warren Fiskus, Uma Mudunuru, Sreedhar Venkannagari, Stacey L Hembruff

Mol Cancer Ther· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells.
Jason A Sprowl, Kerry Reed, Stephen R Armstrong, Carita Lanner, Baoqing Guo, Stacey L Hembruff

Breast Cancer Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heat shock protein 90 inhibitor is synergistic with JAK2 inhibitor and overcomes resistance to JAK2-TKI in human myeloproliferative neoplasm cells.
Warren Fiskus, Srdan Verstovsek, Taghi Manshouri, Rekha Rao, Ramesh Balusu, Stacey L Hembruff

Clin Cancer Res· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and characterization of a novel C-terminal inhibitor of Hsp90 in androgen dependent and independent prostate cancer cells.
Jeffery D Eskew, Takrima Sadikot, Pedro Morales, Alicia Duren, Irene Dunwiddie, Stacey Hembruff

BMC Cancer· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and -independent mechanisms.
Stacey L Hembruff, Iman Jokar, Li Yang, Nikki Cheng

Neoplasia· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of 1C aldoketoreductases and other drug dose-dependent genes upon acquisition of anthracycline resistance.
Zachary W Veitch, Baoqing Guo, Stacey L Hembruff, Adam J Bewick, Allan D Heibein

Pharmacogenet Genomics· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targeting.
Stacey L Hembruff, Nikki Cheng

Cancer Ther· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance.
Stacey L Hembruff, Monique L Laberge, David J Villeneuve, Baoqing Guo, Zachary Veitch

BMC Cancer· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypermethylation of the ABCB1 downstream gene promoter accompanies ABCB1 gene amplification and increased expression in docetaxel-resistant MCF-7 breast tumor cells.
Kerry Reed, Stacey L Hembruff, Monique L Laberge, David J Villeneuve, Gilbert B Côté

Epigenetics· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in expression of cell wall turnover genes accompany inhibition of chromosome segregation by bovine protein kinase C alpha expression in Saccharomyces cerevisiae.
Jason A Sprowl, David J Villeneuve, Baoqing Guo, Andrew J M Young, Stacey L Hembruff

Cell Biol Int· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiles as biomarkers for the prediction of chemotherapy drug response in human tumour cells.
Amadeo M Parissenti, Stacey L Hembruff, David J Villeneuve, Zachary Veitch, Baoqing Guo

Anticancer Drugs· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance.
David J Villeneuve, Stacey L Hembruff, Zachary Veitch, Melanie Cecchetto, William A Dew

Breast Cancer Res Treat· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The optimization of quantitative reverse transcription PCR for verification of cDNA microarray data.
Stacey L Hembruff, David J Villeneuve, Amadeo M Parissenti

Anal Biochem· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-resistance studies of isogenic drug-resistant breast tumor cell lines support recent clinical evidence suggesting that sensitivity to paclitaxel may be strongly compromised by prior doxorubicin exposure.
Baoqing Guo, David J Villeneuve, Stacey L Hembruff, Angie F Kirwan, David E Blais

Breast Cancer Res Treat· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent killing of paclitaxel- and doxorubicin-resistant breast cancer cells by calphostin C accompanied by cytoplasmic vacuolization.
Baoqing Guo, Stacey L Hembruff, David J Villeneuve, Angie F Kirwan, Amadeo M Parissenti

Breast Cancer Res Treat· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis